Abstract
Comparison of MALDI-TOF Mass Spectrometry Analysis of Peripheral Blood and Bone Marrow Based Flow Cytometry for Tracking Measurable Residual Disease (MRD) in Patients with Multiple Myeloma
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have